 | • レポートコード：MRC2-11QY12165 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はB型肝炎治療薬のグローバル市場について調査・分析したレポートです。種類別（B型肝炎ワクチン、抗ウイルス薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別B型肝炎治療薬の競争状況、市場シェア ・世界のB型肝炎治療薬市場：種類別市場規模 2015年-2020年（B型肝炎ワクチン、抗ウイルス薬） ・世界のB型肝炎治療薬市場：種類別市場規模予測 2021年-2026年（B型肝炎ワクチン、抗ウイルス薬） ・世界のB型肝炎治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のB型肝炎治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のB型肝炎治療薬市場分析：米国、カナダ ・ヨーロッパのB型肝炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのB型肝炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のB型肝炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのB型肝炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Bristol-Myers Squibb、Novira Therapeutics、Johnson & Johnson、Abivax、F. Hoffmann- La Roche、Novartis、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hepatitis B Therapeutics Market
The global Hepatitis B Therapeutics market size is projected to reach US$ 2568.8 million by 2026, from US$ 2489 million in 2020, at a CAGR of 3.0%% during 2021-2026.
Global Hepatitis B Therapeutics Scope and Market Size
Hepatitis B Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck
Market segment by Type, the product can be split into
Hepatitis B Vaccine
Anti-viral Drugs
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis B Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Hepatitis B Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hepatitis B Vaccine
1.4.3 Anti-viral Drugs
1.5 Market by Application
1.5.1 Global Hepatitis B Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B Therapeutics Market Perspective (2015-2026)
2.2 Global Hepatitis B Therapeutics Growth Trends by Regions
2.2.1 Hepatitis B Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis B Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis B Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis B Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis B Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Therapeutics Players by Market Size
3.1.1 Global Top Hepatitis B Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Hepatitis B Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis B Therapeutics Market Concentration Ratio
3.2.1 Global Hepatitis B Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis B Therapeutics Revenue in 2019
3.3 Hepatitis B Therapeutics Key Players Head office and Area Served
3.4 Key Players Hepatitis B Therapeutics Product Solution and Service
3.5 Date of Enter into Hepatitis B Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis B Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis B Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis B Therapeutics Market Size by Application (2015-2020)
5.2 Global Hepatitis B Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hepatitis B Therapeutics Market Size (2015-2020)
6.2 Hepatitis B Therapeutics Key Players in North America (2019-2020)
6.3 North America Hepatitis B Therapeutics Market Size by Type (2015-2020)
6.4 North America Hepatitis B Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hepatitis B Therapeutics Market Size (2015-2020)
7.2 Hepatitis B Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Hepatitis B Therapeutics Market Size by Type (2015-2020)
7.4 Europe Hepatitis B Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Hepatitis B Therapeutics Market Size (2015-2020)
8.2 Hepatitis B Therapeutics Key Players in China (2019-2020)
8.3 China Hepatitis B Therapeutics Market Size by Type (2015-2020)
8.4 China Hepatitis B Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hepatitis B Therapeutics Market Size (2015-2020)
9.2 Hepatitis B Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Hepatitis B Therapeutics Market Size by Type (2015-2020)
9.4 Japan Hepatitis B Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hepatitis B Therapeutics Market Size (2015-2020)
10.2 Hepatitis B Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis B Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis B Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Hepatitis B Therapeutics Market Size (2015-2020)
11.2 Hepatitis B Therapeutics Key Players in India (2019-2020)
11.3 India Hepatitis B Therapeutics Market Size by Type (2015-2020)
11.4 India Hepatitis B Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hepatitis B Therapeutics Market Size (2015-2020)
12.2 Hepatitis B Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis B Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis B Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Hepatitis B Therapeutics Introduction
13.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Introduction
13.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Novira Therapeutics
13.3.1 Novira Therapeutics Company Details
13.3.2 Novira Therapeutics Business Overview
13.3.3 Novira Therapeutics Hepatitis B Therapeutics Introduction
13.3.4 Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.3.5 Novira Therapeutics Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Hepatitis B Therapeutics Introduction
13.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Abivax
13.5.1 Abivax Company Details
13.5.2 Abivax Business Overview
13.5.3 Abivax Hepatitis B Therapeutics Introduction
13.5.4 Abivax Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.5.5 Abivax Recent Development
13.6 F. Hoffmann- La Roche
13.6.1 F. Hoffmann- La Roche Company Details
13.6.2 F. Hoffmann- La Roche Business Overview
13.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Introduction
13.6.4 F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.6.5 F. Hoffmann- La Roche Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Hepatitis B Therapeutics Introduction
13.7.4 Novartis Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Hepatitis B Therapeutics Introduction
13.8.4 Merck Revenue in Hepatitis B Therapeutics Business (2015-2020)
13.8.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hepatitis B Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Hepatitis B Therapeutics Revenue
Table 3. Ranking of Global Top Hepatitis B Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hepatitis B Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hepatitis B Vaccine
Table 6. Key Players of Anti-viral Drugs
Table 7. Global Hepatitis B Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hepatitis B Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hepatitis B Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hepatitis B Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Hepatitis B Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hepatitis B Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hepatitis B Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Hepatitis B Therapeutics Players
Table 18. Global Hepatitis B Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hepatitis B Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Therapeutics as of 2019)
Table 21. Global Hepatitis B Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hepatitis B Therapeutics Product Solution and Service
Table 24. Date of Enter into Hepatitis B Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hepatitis B Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Hepatitis B Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Hepatitis B Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hepatitis B Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 34. North America Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 36. North America Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 40. Europe Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 46. China Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 48. China Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 52. Japan Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 64. India Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 66. India Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hepatitis B Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hepatitis B Therapeutics Market Share (2019-2020)
Table 70. Central & South America Hepatitis B Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hepatitis B Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Hepatitis B Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hepatitis B Therapeutics Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Novira Therapeutics Company Details
Table 85. Novira Therapeutics Business Overview
Table 86. Novira Therapeutics Product
Table 87. Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 88. Novira Therapeutics Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Abivax Company Details
Table 95. Abivax Business Overview
Table 96. Abivax Product
Table 97. Abivax Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 98. Abivax Recent Development
Table 99. F. Hoffmann- La Roche Company Details
Table 100. F. Hoffmann- La Roche Business Overview
Table 101. F. Hoffmann- La Roche Product
Table 102. F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 103. F. Hoffmann- La Roche Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Company Details
Table 112. Merck Revenue in Hepatitis B Therapeutics Business (2015-2020) (Million US$)
Table 113. Merck Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Hepatitis B Vaccine Features
Figure 3. Anti-viral Drugs Features
Figure 4. Global Hepatitis B Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Hepatitis B Therapeutics Report Years Considered
Figure 9. Global Hepatitis B Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hepatitis B Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Hepatitis B Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hepatitis B Therapeutics Market Share by Players in 2019
Figure 14. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2019
Figure 16. North America Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hepatitis B Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
C型肝炎治療薬の世界市場（～2026年） Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc. Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepa…- B型肝炎ウイルス（HBV）の世界市場（～2026年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…
- C型肝炎ウイルスエンベロープタンパク質E2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis C Virus Envelope Protein E2 Market The global Hepatitis C Virus Envelope Protein E2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis C Virus Envelope Protein E2 S…
- C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- ウイルス性肝炎・レトロウイルス診断検査の世界市場（～2026年） Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patien…